PHOTO CREDIT: University of Utah
A simulation of an ice inhibiting molecule. The molecule, in red, is like a weight on the surface of the ice crystal, curving it and preventing further ice crystal growth.
Cell therapies hold great promise for revolutionizing the treatment of cancers and autoimmune diseases. But this multibillion-dollar industry requires long-term storage of cells at super-cold cryogenic conditions, while ensuring they’ll continue to function upon thawing. However, these cold temperatures trigger the formation and growth of ice, which can pierce and tear apart cells. Research published in the Journal of the American Chemical Society by University of Utah chemists Pavithra Naullage and Valeria Molinero provides the foundation to design efficient polymers that can prevent the growth of ice that damages cells.
Nature’s antifreeze
Current strategies to cryopreserve cells and organs involve bathing them with large amounts of dimethyl sulfoxide, a toxic chemical that messes up ice formation but stresses the cells, decreasing their odds for survival.
Nature, however, has found a way to keep organisms alive under extreme cold conditions: antifreeze proteins. Fish, insects and other cold-blooded organisms have evolved potent antifreeze glycoproteins that bind to ice crystallites and halt them from growing and damaging cells.
The growing area of cell-based therapeutics demands the development of potent inhibitors of ice recrystallization that can compete in activity with natural antifreeze glycoproteins but do not have the cost and toxicity of dimethyl sulfoxide. This demand has propelled the synthesis of polymers that mimic the action of antifreeze glycoproteins. But the most potent synthetic ice recrystallization inhibitor found to date, polyvinyl alcohol (PVA), is orders of magnitude less potent than natural glycoproteins.
“Efforts to identify stronger inhibitors for ice growth seem to have stalled, as there is not yet a molecular understanding of the factors that limits the ice recrystallization inhibition efficiency of polymers,” Molinero says.
A hidden polymer design variable
How do molecules prevent ice crystals from getting bigger? Molecules that bind strongly to ice pin its surface—like stones on a pillow—making the ice front develop a curved surface around the molecules. This curvature destabilizes the ice crystal, halting its growth. Molecules that stay bound to ice for times longer than the time it takes to grow ice crystals succeed in preventing further growth and recrystallization.
Molinero and Naullage used large-scale molecular simulations to elucidate the molecular underpinnings of how flexibility, length and functionalization of polymers control their binding to ice and their efficiency to prevent ice growth. Their study shows that the bound time of the molecules at the ice surface is controlled by the strength of their ice binding coupled with the length of the polymer and how fast they propagate on the ice surface.
“We found that the efficiency of flexible polymers in halting ice growth is limited by the slow propagation of their binding to ice,” Molinero says.
The study dissects the various factors that control the binding of flexible polymers to ice and that account for the gap in potency of PVA and natural antifreeze glycoproteins. In a nutshell, each block of antifreeze glycoproteins binds more strongly to ice than PVA does, and are also favored by their secondary molecular structure that segregates the binding and non-binding blocks to allow them to attach faster to ice to stop its growth.
“To our knowledge, this work is first to identity the time of propagation of binding as a key variable in the design of efficient ice-binding flexible polymers,” Naullage says. “Our study sets the stage for the de novo design of flexible polymers that can meet or even surpass the efficiency of antifreeze glycoproteins and make an impact in biomedical research.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Cryogenics
- Industrial Oxygen Market | One the Most Booming Industry in Upcoming Years Due to Global Demand by 2031
As per the study, the industrial oxygen market is anticipated to witness a growth rate of 7.9% during the coming assessment period. Growing demand for ...
- A New Era of Low-Energy Oxygen Generation: PCI Gases Celebrates its 1,000th Deployable Oxygen Concentration System (DOCS) Unit Milestone
PCI has reached the impressive number of 1,000th DOCS unit manufactured and distributed (PRUnderground) May 24th, 2022Fifteen years ago Pacific ...
- French start-up selects Cryomec tech for orbital launcher
The French developer of nanosatellites launch services, Venture Orbital Systems (Venture) will use Fives Cryomec (Fives) LABS technology to test the Navier Mk2 engine that is set to power its Zephyr ...
- QED-C® Announces Four Projects Designed To Advance Cryogenics For Quantum Information Science And Technology'
The program aims to address gaps and barriers to progress in quantum computing, networking, communication and sensing MENLO PARK, Calif., May 23, 2022 /PRNewswire/ -- The Quantum Economic ...
- LNG Cryogenic Equipment Market has Huge Demand Top Key Players Profiling – Wessington Cryogenics, Air Liquide, Cryofab, Inc., INOX India Limited
The recent report on “Global LNG Cryogenic Equipment Market Report 2022 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2030” offered by Credible Markets, comprises of a ...
Go deeper with Google Headlines on:
Cryogenics
Go deeper with Bing News on:
Antifreeze glycoproteins
- ProtoKinetix, Incorporated (OTCMKTS:PKTX) Sees Large Increase in Short Interest
ProtoKinetix, Incorporated (OTCMKTS:PKTX – Get Rating) was the target of a significant increase in short interest in April. As of April 30th, there was short interest totalling 56,900 shares, an ...
- ProtoKinetix, Incorporated (OTCMKTS:PKTX) Sees Significant Growth in Short Interest
ProtoKinetix, Incorporated (OTCMKTS:PKTX – Get Rating) saw a large increase in short interest in April. As of April 30th, there was short interest totalling 56,900 shares, an increase of 3,693.3% from ...
- ProtoKinetix, Incorporated (OTCMKTS:PKTX) Sees Significant Decline in Short Interest
ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins ...
- Antifreeze Protein Market Outlook By Size, Share, Future Growth and Forecast
The global antifreeze proteins market stood at USD 3.9 billion in 2021 and is likely to reach USD 29.8 billion by 2030,growing at a CAGR of 39.4% during the forecast period, 2022-2030. Antifreeze ...
- Antifreeze Proteins Market Projected to Garner Significant Revenues by 2026
The report “Antifreeze Proteins Market by Type (Type I, Type III, and Antifreeze glycoproteins), Form (Solid, and Liquid), End-use (Medical, Food and Cosmetics), Source (Fish, Plants ...